Clovis Oncology, Inc. Convertible Debt, Current
Clovis Oncology, Inc. had Convertible Debt, Current of $438.32 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2022-11-09
- 2022-09-30: Convertible Debt, Current $438.32M.
- 2021-06-30: Convertible Debt, Current $64.35M.
- 2021-03-31: Convertible Debt, Current $64.28M.
- 2020-12-31: Convertible Debt, Current $64.20M.
| Period end | Convertible Debt, Current |
|---|---|
| 2022-09-30 | $438.32M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $64.35M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $64.28M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $64.20M 10-K · filed 2022-02-24 |